Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024 0

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024 0

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Updated on: February 01,2024 16

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Updated on:February 01,2024 16

Study discovers that tumor mutation burden predicts survival outcome

by Tom Wilemon,Vanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and m

Updated on: January 28,2024 19

Study discovers that tumor mutation burden predicts survival outcome

by Tom Wilemon,Vanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and m

Updated on:January 28,2024 19

How tumors mutate their way out of a crisis—and become drug resistant in the process

byWeizmann Institute of ScienceHuman lung cancer cells under the microscope, before (left) and after (right) treatment with an anticancer drug, which causes DNA breaks (green) in the cell nuclei

Updated on: January 21,2024 18

How tumors mutate their way out of a crisis—and become drug resistant in the process

byWeizmann Institute of ScienceHuman lung cancer cells under the microscope, before (left) and after (right) treatment with an anticancer drug, which causes DNA breaks (green) in the cell nuclei

Updated on:January 21,2024 18

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024 5

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024 5

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow

Updated on: February 23,2024 15

New bacterial therapy approach to treat lung cancer

by Holly Evarts,Columbia University School of Engineering and Applied ScienceFluorescence microscopy image of lung cancer cells stained with antibodies against proteins involved in cellular grow

Updated on:February 23,2024 15

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre

Updated on: April 01,2024 10

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre

Updated on:April 01,2024 10

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024 13

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024 13

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on: March 14,2024 20

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on:March 14,2024 20

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on: January 04,2024 9

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on:January 04,2024 9

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on: January 30,2024 12

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on:January 30,2024 12

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on: December 28,2023 10

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on:December 28,2023 10